Through single-cell sequencing, studies have identified a large number of T-cell subsets in CTCL patients expressing markers such as CXCR3+, GNLY+, CREM+, and MKI67+ [36]. The gene discussed is CXCR3; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.